- Disease: Respiratory syncytial virus infection
- Study type: Observational Cohort Study, Prevention
- Study type descriptors: Prospective, Multicentre
- Objective: To evaluate the effectiveness of nirsevimab in preventing hospitalisations for confirmed RSV infection and the impact of a strategy of immunisation at birth
- Number of participants enrolled: 1177
- Study enrolling from to
- Study includes follow-up for 4 months
Study Data
- General population
- Infants (<1 year)
- Hospital
- Respiratory syncytial virus
- Respiratory syncytial virus infection
- Pharmacological intervention
- Monoclonal antibodies
- Nirsevimab
External Links
Other information
Funders/Sponsors:
- https://ror.org/00ca2c886
If you would like to contact the Principal Investigator of the study please email: ccb@ateneo.univr.it
The data is updated up to